The Hemosep Story

The development of Hemosep has been an exciting journey – and it’s not over yet!

In partnership with Professor Terence Gourlay at the University of Strathclyde, we have produced an exciting new blood recycling machine for which Brightwake holds the world rights.

The first full clinical trial of Hemosep involved more than 50 patients at the University of Kirikkale University Hospital in Ankara, Turkey. Click here to read more about the trial, which confirmed Hemosep’s huge potential.

Clinical research is continuing in the UK through further trials at a number of NHS trusts.

Nottingham University Hospitals (NUH) have successfully used Hemosep during heart surgery on a Jehovah’s Witness. This world first attracted major news coverage, some of which you can see here:

Academic papers are being prepared by NUH and by University Hospitals of North Midlands NHS Trust, where initial indications have also been encouraging. A further trial is underway at Guy’s and St Thomas’s in London.

Clinicians at Papworth Hospital have also reported their findings following a trial involving Hemosep: A randomised controlled study of the effect of a novel blood salvage and concentration system on patient haematocrit after cardiac surgery with cardiopulmonary bypass.

This paper is based on a blood processing time of 20 minutes, whereas we recommend 40 minutes. The Papworth research indicates the longer time is needed to ensure adequate performance, while the use of fluids and taking of samples from patients may also have affected the blood concentration outcomes.

As with all research, we will use these findings to continue to improve Hemosep and expand its applications.

Meanwhile, global interest in Hemosep is growing rapidly. We now have distributors in place for Europe, Africa, the Middle East, Australia, South East Asia, Canada and South America. FDA approval for Hemosep in the United States is expected shortly.

If you want to know more or be part of the Hemosep story, please contact info@advancissurgical.com

 

References

Gunaydin S. Novel Ultrafiltration Technique for Blood Conservation in Cardiac Operations. The Annals of thoracic surgery. 2013-06-01;95:2148.

Hogan, M. et.al. A randomised controlled study of the effect of a novel blood salvage and concentration system on patient haematocrit after cardiac surgery with cardiopulmonary bypass. ACTA Spring Meeting, London, 2014.